anti-glycan monoclonal antibody (Scancell)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Nameanti-glycan monoclonal antibody (Scancell)
Drug Alias Nameanti-glycan monoclonal antibody (Genmab)SC-134
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > T cell engagers
Mechanisms of ActionGanglioside fucosyl GM1 inhibitors
TargetsGanglioside fucosyl GM1
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScancell Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenmab A/S
Inactive CompaniesScancell Ltd
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A